<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref92">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Marjuki</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Mishin</surname>
    <given-names>V. P.</given-names>
   </name>
   <name>
    <surname>Chesnokov</surname>
    <given-names>A. P.</given-names>
   </name>
   <name>
    <surname>De La Cruz</surname>
    <given-names>J. A.</given-names>
   </name>
   <name>
    <surname>Fry</surname>
    <given-names>A. M.</given-names>
   </name>
   <name>
    <surname>Villanueva</surname>
    <given-names>J.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2014</year>). 
  <article-title>An investigational antiviral drug, DAS181, effectively inhibits replication of zoonotic influenza A virus subtype H7N9 and protects mice from lethality</article-title>. 
  <source>J. Infect. Dis.</source>
  <volume>210</volume>, 
  <fpage>435</fpage>â€“
  <lpage>440</lpage>. 
  <pub-id pub-id-type="doi">10.1093/infdis/jiu105</pub-id>, PMID: 
  <?supplied-pmid 24569063?>
  <pub-id pub-id-type="pmid">24569063</pub-id>
 </mixed-citation>
</ref>
